Pharmacogenetic evaluation of ABCB1, Cyp2C9, Cyp2C19 and methylene tetrahydrofolate reductase polymorphisms in teratogenicity of anti-epileptic drugs in women with epilepsy

Aim: Pregnancy in women with epilepsy (WWE) who are on anti-epileptic drugs (AEDs) has two- to three-fold increased risk of fetal malformations. AEDs are mostly metabolized by Cyp2C9, Cyp2C19 and Cyp3A4 and transported by ABCB1. Patients on AED therapy can have folate deficiency. We hypothesize that the polymorphisms in ABCB1, Cyp2C9, Cyp2C19 and methylene tetrahydrofolate reductase (MTHFR) might result in differential expression resulting in differential drug transport, drug metabolism and folate metabolism, which in turn may contribute to the teratogenic impact of AEDs. Materials and Methods: The ABCB1, Cyp2C9, Cyp2C19 and MTHFR polymorphisms were genotyped for their role in teratogenic potential and the nature of teratogenecity in response to AED treatment in WWE. The allelic, genotypic associations were tested in 266 WWE comprising of 143 WWE who had given birth to babies with WWE-malformation (WWE-M) and 123 WWE who had normal offsprings (WWE-N). Results: In WWE-M, CC genotype of Ex07 + 139C/T was overrepresented (P = 0.0032) whereas the poor metabolizer allele *2 and *2 *2 genotype of CYP2C219 was significantly higher in comparison to WWE-N group (P = 0.007 and P = 0.005, respectively). All these observations were independent of the nature of malformation (cardiac vs. non cardiac malformations). Conclusion: Our study indicates the possibility that ABCB1 and Cyp2C19 may play a pivotal role in the AED induced teratogenesis, which is independent of nature of malformation. This is one of the first reports indicating the pharmacogenetic role of Cyp2C19 and ABCB1 in teratogenesis of AED in pregnant WWE.

[1]  T. Tomson,et al.  Teratogenic effects of antiepileptic drugs , 2012, The Lancet Neurology.

[2]  M. Banerjee,et al.  Antipsychotic drug dosage and therapeutic response in schizophrenia is influenced by ABCB1 genotypes: a study from a south Indian perspective. , 2012, Pharmacogenomics.

[3]  W. Hauser,et al.  Comparative safety of antiepileptic drugs during pregnancy , 2012, Neurology.

[4]  B. Wlodarczyk,et al.  Genetic basis of susceptibility to teratogen induced birth defects , 2011, American journal of medical genetics. Part C, Seminars in medical genetics.

[5]  Wolfgang Löscher,et al.  Several major antiepileptic drugs are substrates for human P-glycoprotein , 2008, Neuropharmacology.

[6]  C. D'Giano,et al.  ABC Transporters during Epilepsy and Mechanisms Underlying Multidrug Resistance in Refractory Epilepsy , 2007, Epilepsia.

[7]  S. Mueller,et al.  Intestinal expression of cytochrome P450 enzymes and ABC transporters and carbamazepine and phenytoin disposition , 2007, Acta neurologica Scandinavica.

[8]  D. Goldstein,et al.  The controversial association of ABCB1 polymorphisms in refractory epilepsy: An analysis of multiple SNPs in an Irish population , 2007, Epilepsy Research.

[9]  M. Banerjee,et al.  A crypto-Dravidian origin for the nontribal communities of South India based on human leukocyte antigen class I diversity. , 2006, Tissue antigens.

[10]  B. Irwin,et al.  Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[11]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[12]  A. Rabinowicz,et al.  Neuronal MDR-1 Gene Expression and Persistent Low Levels of Anticonvulsants in a Child with Refractory Epilepsy , 2004, Therapeutic drug monitoring.

[13]  Thierry Buclin,et al.  Polymorphisms in Human MDR1 (P‐glycoprotein): Recent Advances and Clinical Relevance , 2004, Clinical pharmacology and therapeutics.

[14]  F. Dudbridge.  Pedigree disequilibrium tests for multilocus haplotypes , 2003, Genetic epidemiology.

[15]  A. Richens,et al.  Epilepsy and pregnancy: Report of an Epilepsy Research Foundation Workshop , 2003, Epilepsy Research.

[16]  J. Ott,et al.  Power and Sample Size Calculations for Case-Control Genetic Association Tests when Errors Are Present: Application to Single Nucleotide Polymorphisms , 2002, Human Heredity.

[17]  A. D. Rodrigues,et al.  Cytochrome P450 pharmacogenetics in drug development: in vitro studies and clinical consequences. , 2002, Current drug metabolism.

[18]  Michael Boehnke,et al.  Probability of detection of genotyping errors and mutations as inheritance inconsistencies in nuclear-family data. , 2002, American journal of human genetics.

[19]  E A Harvey,et al.  The teratogenicity of anticonvulsant drugs. , 2001, The New England journal of medicine.

[20]  K. Radhakrishnan,et al.  Pregnancy in women with epilepsy : preliminary results of Kerala registry of epilepsy and pregnancy. , 2001, Neurology India.

[21]  Quanhe Yang,et al.  5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. , 2000, American journal of epidemiology.

[22]  U. Brinkmann,et al.  Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Sridharan,et al.  Prevalence and Pattern of Epilepsy in India , 1999, Epilepsia.

[24]  E. Reynolds.  Mental effects of anticonvulsants, and folic acid metabolism. , 1968, Brain : a journal of neurology.

[25]  M. Pratten,et al.  Association of anxiolytic drugs diazepam and lorazepam, and the antiepileptic valproate, with heart defects--effects on cardiomyocytes in micromass (MM) and embryonic stem cell culture. , 2011, Reproductive toxicology.

[26]  G. Koren,et al.  Teratogenic determinants of first-trimester exposure to antiepileptic medications. , 2011, Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique.

[27]  R. Finnell,et al.  Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 1: Animal studies. , 1991, Reproductive toxicology.